Among these, Apolipoprotein L1 (APOL1) has emerged as a gene of particular interest due to its central role in APOL1-associated nephropathies, a group of disorders where FSGS represents a prominent clinical manifestation [9,10]. This evidence concerns the gene APOL1 and focal segmental glomerulosclerosis.